Blood biomarkers in frontotemporal dementia: a longitudinal study

Blood biomarkers in frontotemporal dementia: a longitudinal study - Longitudinal blood biomarkers in frontotemporal dementia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44528

Enrollment

Registered

2017-11-27

Start date

2017-10-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dementia frontotemporal dementia Pick's disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with frontotemporal dementia who visited our referral centre and were diagnosed according to International Consensus Criteria. All clinical subtypes will be included, both genetic and sporadic.

Exclusion criteria

Exclusion criteria: Patients with a history of unrelated neurological disorders that could influence cognitive performance (such as normal pressure hydrocephalus, brain tumours, developmental disorders et cetera).

Design outcomes

Primary

Measure	Time frame
1. Longitudinal dynamics of biomarkers in blood of patients with frontotemporal dementia 2. Relationship between longitudinal change of blood biomarkers and severity and rate of cognitive decline in patients with frontotemporal dementia.	—

Secondary

Measure	Time frame
NA.	—

Countries

Netherlands

Outcome results